LOCALLY ADVANCED RECTAL CANCER (LARC)
Clinical trials for LOCALLY ADVANCED RECTAL CANCER (LARC) explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED RECTAL CANCER (LARC) trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED RECTAL CANCER (LARC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists test Four-Pronged attack to shrink rectal tumors before surgery
Disease control Recruiting nowThis study is testing a new combination of treatments given before surgery for a specific type of rectal cancer that has not spread to distant organs. The goal is to see if a short course of radiation, followed by chemotherapy and two other drugs (an immunotherapy and a targeted …
Matched conditions: LOCALLY ADVANCED RECTAL CANCER (LARC)
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Apr 04, 2026 05:21 UTC
-
Cancer Drug's Real-World performance under the microscope
Disease control Recruiting nowThis study is observing how well the drug dostarlimab works for patients with a specific type of advanced rectal cancer in real-world settings, outside of a controlled clinical trial. It will track 50 patients who have already received or will receive the drug as part of their st…
Matched conditions: LOCALLY ADVANCED RECTAL CANCER (LARC)
Sponsor: National Cancer Institute, Naples • Aim: Disease control
Last updated Apr 04, 2026 05:21 UTC
-
Virus weapon targets advanced rectal cancer in new trial
Disease control Recruiting nowThis early-stage trial is testing the safety and initial effectiveness of a new drug called NG-350A when given alongside standard chemoradiation for locally advanced rectal cancer. NG-350A is a modified virus designed to selectively infect and activate the immune system against t…
Matched conditions: LOCALLY ADVANCED RECTAL CANCER (LARC)
Phase: PHASE1 • Sponsor: Akamis Bio • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug combo aims to shrink tumors and spare rectums
Disease control Recruiting nowThis study is testing a new treatment approach for people with a common type of advanced rectal cancer. It combines a short course of radiation, standard chemotherapy, and two new immunotherapy drugs to try to shrink tumors before surgery. The main goal is to see if this combinat…
Matched conditions: LOCALLY ADVANCED RECTAL CANCER (LARC)
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Blood test could tell doctors if rectal cancer treatment is working
Knowledge-focused Recruiting nowThis study aims to see if a personalized blood test can predict how well pre-surgery treatment works for patients with locally advanced rectal cancer. Researchers will collect blood and tissue samples from 60 patients at different times during their treatment. They will use this …
Matched conditions: LOCALLY ADVANCED RECTAL CANCER (LARC)
Sponsor: Beijing Friendship Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC